share_log

科濟藥業-B：補充通函 - (I) 重選退任董事，及 (II) 股東週年大會補充通告

CARSGEN-B: SUPPLEMENTAL CIRCULAR - (I) RE-ELECTION OF THE RETIRING DIRECTOR, AND (II) SUPPLEMENTAL NOTICE OF ANNUAL GENERAL MEETING

Hong Kong Stock Exchange ·  Apr 30 09:54
Summary by Moomoo AI
科濟藥業-B於2024年4月30日發布補充通函，宣布將於2024年5月21日舉行的股東週年大會上，考慮重選周文博士為獨立非執行董事的決議案。周博士於2024年4月29日起任獨立非執行董事，任期至下屆股東週年大會。提名及企業管治委員會已審閱周博士的資格、經驗及獨立性，並向董事會建議其連任。股東若無法出席大會，需根據補充通函指示，填妥及交回經修訂代表委任表格。該表格及補充通函可於公司及香港聯合交易所有限公司網站上查閱。
科濟藥業-B於2024年4月30日發布補充通函，宣布將於2024年5月21日舉行的股東週年大會上，考慮重選周文博士為獨立非執行董事的決議案。周博士於2024年4月29日起任獨立非執行董事，任期至下屆股東週年大會。提名及企業管治委員會已審閱周博士的資格、經驗及獨立性，並向董事會建議其連任。股東若無法出席大會，需根據補充通函指示，填妥及交回經修訂代表委任表格。該表格及補充通函可於公司及香港聯合交易所有限公司網站上查閱。
KOCHI PHARMACEUTICAL-B ISSUED A SUPPLEMENTAL CIRCULAR ON APRIL 30, 2024 ANNOUNCING THAT IT WOULD CONSIDER A RESOLUTION TO RE-ELECT DR. CHU WEN AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR AT ITS ANNUAL GENERAL MEETING TO BE HELD ON MAY 21, 2024. Dr. Zhou became an Independent Non-Executive Director with effect from 29 April 2024 until the next Annual General Meeting. The Nomination and Corporate Governance Committee has reviewed Dr Zhou's qualifications, experience and independence and has recommended him to the Board of Directors for his continued appointment. If shareholders are unable to attend the General Meeting, they are required to complete and submit the amended Proxy Form in accordance with the instructions of the Supplementary Circular. The form and supplementary circular are available on the Company's website and the United Stock Exchange Limited.
KOCHI PHARMACEUTICAL-B ISSUED A SUPPLEMENTAL CIRCULAR ON APRIL 30, 2024 ANNOUNCING THAT IT WOULD CONSIDER A RESOLUTION TO RE-ELECT DR. CHU WEN AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR AT ITS ANNUAL GENERAL MEETING TO BE HELD ON MAY 21, 2024. Dr. Zhou became an Independent Non-Executive Director with effect from 29 April 2024 until the next Annual General Meeting. The Nomination and Corporate Governance Committee has reviewed Dr Zhou's qualifications, experience and independence and has recommended him to the Board of Directors for his continued appointment. If shareholders are unable to attend the General Meeting, they are required to complete and submit the amended Proxy Form in accordance with the instructions of the Supplementary Circular. The form and supplementary circular are available on the Company's website and the United Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more